Eleuterio Ferrannini

52PUBLICATIONS
110CO-AUTHORS
Food properties (incl. characteristics and health benefits)Molecular targetsSport and exercise psychologyNutritional epidemiologyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (52)

|Mar 12, 2026
Impact of canagliflozin on the cardiorenal effects of dietary sodium intake in type 2 diabetes: a post hoc analysis of the CREDENCE trial.

Martina Chiriacò, Domenico Tricò, Alberto Giannoni

|Mar 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Carmella Evans-Molina, Stephen E Gitelman, Andrea Mari

|Sep 02, 2025
Effects of Dorzagliatin, a Glucokinase Activator, on α- and β-Cell Function in Individuals With Impaired and Normal Glucose Tolerance.

Zhengli Bai, Ke Wang, Tiffany Yau

|Jul 08, 2024
GLP-1 Receptor Agonist Treatment Improves Fasting and Postprandial Lipidomic Profiles Independently of Diabetes and Weight Loss.

Giuseppe Della Pepa, Bárbara G Patrício, Fabrizia Carli

|Jun 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study.

Aino Latva-Rasku, Eleni Rebelos, Jouni Tuisku

|Dec 06, 2023
High Mannose Correlates With Surrogate Indexes of Insulin Resistance and Is Associated With an Increased Risk of Cardiovascular Events Independently of Glycemic Status and Traditional Risk Factors.

Elena Fortin, Beatrice Campi, Ele Ferrannini

Pageof 9

Frequent Collaborators

8 joint publications

Andrea Mari

7 joint publications

Eleni Rebelos

6 joint publications

Pirjo Nuutila

4 joint publications

Julio Rosenstock